Aldeyra Therapeutics Inc. is a biotechnology company that develops and commercializes novel therapeutics to treat immune-mediated diseases. Their focus is on diseases that result from inflammation and toxic chemical stressors, employing a proprietary technology platform to create small molecule drug candidates. Their mission is to provide innovative solutions for patients with unmet medical needs.
Notification